According to Cocrystal Pharma
's latest financial reports the company has NZ$11.61 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | NZ$41.67 M | -28.77% |
2022-12-31 | NZ$58.5 M | -31.93% |
2021-12-31 | NZ$85.94 M | 87.86% |
2020-12-31 | NZ$45.74 M | 315.36% |
2019-12-31 | NZ$11.01 M | 171.33% |
2018-12-31 | NZ$4.05 M | 285.44% |
2017-12-31 | NZ$1.05 M | -79.76% |
2016-12-31 | NZ$5.2 M | -61.6% |
2015-12-31 | NZ$13.55 M | 78.62% |
2014-12-31 | NZ$7.58 M | 503.02% |
2013-12-31 | NZ$1.25 M | 12677.51% |
2012-12-31 | NZ$0 M | -98.15% |
2011-12-31 | NZ$0.53 M | 63.65% |
2010-12-31 | NZ$0.32 M | 449.89% |
2009-12-31 | NZ$0.05 M | -53.88% |
2008-12-31 | NZ$0.12 M | -10.37% |
2007-12-31 | NZ$0.14 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Merck MRK | NZ$15.48 B | 133,233.33% | ๐บ๐ธ USA |
![]() USANA USNA | NZ$0.30 B | 2,495.19% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | NZ$65.07 B | 560,238.10% | ๐บ๐ธ USA |
![]() Nature's Sunshine Products NATR | NZ$0.14 B | 1,149.62% | ๐บ๐ธ USA |